Notice Pursuant to the National Cooperative Research and Production Act of 1993-Biopharmaceutical Manufacturing Preparedness Consortium, 104212 [2024-30402]

Download as PDF ddrumheller on DSK120RN23PROD with NOTICES1 104212 Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices LLC, Reston, VA; Mindboard, Inc., Sterling, VA; Mosaic ATM, Inc., Leesburg, VA; N2L, Inc., New Market, AL; National Instruments Corporation, Austin, TX; North American Wave Engine Corporation, Baltimore, MD; Omnitek Partners, LLC, Ronkonkoma, NY; Onyx Aerospace, Huntsville, AL; Park-Tours, Inc., dba Left Coast Engineering, Escondido, CA; Parry Labs, LLC, Alexandria, VA; Phoenix Waste Solutions, Inc., Chauvin, LA; Pliant Energy Systems, Inc., Brooklyn, NY; Polaris Sensor Technologies, Inc., Huntsville, AL; Precise Systems, Lexington Park, MD; Qualcomm Technologies, Inc., San Diego, CA; Raft, LLC, Reston, VA; Rantec Power Systems, Inc., Los Osos, CA; RapidFlight Holdings, LLC, Manassas, VA; Safire Technology Group, Inc., Mclean, VA; Skylark Labs, Inc., Dover, DE; Strategic Technology Consulting, LLC, Chantilly, VA; Strogen Strategic Sustainability, LLC, Washington, DC; Symbiosis.io, LLC, Smyrna, GA; Tactical Electronics and Military Supply, LLC, Broken Arrow, OK; Tapestry Solutions, San Diego, CA; TDP, Inc., Loveland, CO; The Dewey Electronics Corporation, Oakland, NJ; The Hard Yards, LLC, dba BlackSea Technologies, Arlington, VA; The Pennsylvania State University—Applied Research Laboratory, State College, PA; The Rector and Visitors of the University of Virginia, Charlottesville, VA; Tetramer Technologies, LLC, Pendleton, SC; Tiami, LLC, Elk Grove, CA; Tiger Team Engineering, LLC, Sheridan, WY; Torch Technologies, Inc., Huntsville, AL; Trustees of Indiana University, Bloomington, IN; TurnAround Factor, Ashland, VA; UberEther, Inc., Sterling, VA; Ultrasea, Inc., East Kingston, NH; Universal Solutions International, Inc., Newport News, VA; Vega Technology Group, LLC, North Canton, OH; Wright Electric, Inc., Malta, NY; and WWM Solutions, LLC, Washington, DC have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and EMC2 intends to file additional written notifications disclosing all changes in membership. On January 11, 2024, EMC2 filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on March 13, 2024 (89 FR 18439). The last notification was filed with the Department on June 14, 2024. A notice was published in the Federal Register pursuant to section 6(b) of the VerDate Sep<11>2014 20:12 Dec 19, 2024 Jkt 265001 Act on September 12, 2024 (89 FR 74287). Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. [FR Doc. 2024–30416 Filed 12–19–24; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Biopharmaceutical Manufacturing Preparedness Consortium Notice is hereby given that, on October 3, 2024, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Biopharmaceutical Manufacturing Preparedness Consortium (‘‘BioMaPConsortium’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Asimov, Inc., Boston, MA; Bayer Healthcare LLC, Whippany, NJ; CHIMunomics, Ltd., Horsell, UNITED KINGDOM; Carnegie Mellon University, Pittsburgh, PA; Emergent Product Development Gaithersburg, Inc., Gaithersburg, MD; Enzene, Inc., Pennington, NJ; GE Medical Systems Information Technologies, Inc. d.b.a. GE HealthCare Technology & Innovation Center, Niskayuna, NY; Just-Evotec Biologics, Seattle, WA; Medbio LLC, Grand Rapids, MI; Molding Services of Illinois, Inc., Olney, IL; Novas Bio, Inc., Union City, CA; Qoolabs, Inc., Carlsbad, CA; SPOC Proteomics, Inc., Scottsdale, AZ; SaniSure, Inc., Camarillo, CA; AlphaGem Bio, Inc., Fremont, CA; Azure Medical, Inc., La Verne, CA; BioFactura, Inc., Frederick, MD; Brightstar Innovations Group LLC, Arlington, VA; Croda, Inc., Mill Hall, PA; Hamilton Company, Reno, NV; Komo Biosciences, Inc., Cambridge, MA; Mustard Seed PMO LLC, West Chester, PA; Nephron Nitrile LLC, West Columbia, SC; Rutgers University, Piscataway, NJ; The Tiny Cargo Company, Roanoke, VA; VGXI, Inc., Conroe, TX; Wild Microbes Company, Cambridge, MA; Arcology, Inc., Culver City, CA; Avery Digital Data, Inc., La Jolla, CA; Louis M Gerson Co, Inc., Middleboro, MA; Mark Cuban Cost Plus PO 00000 Frm 00141 Fmt 4703 Sfmt 9990 Drug Company, PBC, Dallas, TX; Vulcan Bioworks LLC, Dover, DE; Arcturus Therapeutics Holdings, Inc., San Diego, CA; Dentec Safety Specialists Corp., Lenexa, KS; Guide Biomedical Solutions LLC, Media, PA; Integral Molecular, Philadelphia, PA; Shreenika Pioneering, San Diego, CA; Applied Research Associates, Albuquerque, NM; DemeTech Corp., Miami, FL; Quantoom Biosciences SA, Nivelles, BELGIUM; Reusable Respirators LLC, Panama City, FL; SafeSource Direct, LLC, Broussard, LA; Vaxine Pty Ltd., Warradale, AUSTRALIA; 3M Company, St. Paul, MN; Amneal Pharmaceuticals of New York, LLC, Brookhaven, NY; CMMCM LLC, Las Vegas, NV; Foothill Scientific Associates, Lake Forest, CA; Innerspace GmbH, Insnbruck, AUSTRIA; Jurata Thin Film, Inc., Chapel Hill, NC; LTS Lohmann Therapie-Systeme AG, Andernach, GERMANY; O&M Halyard, Inc., Alpharetta, GA; PNUVAX, Inc., Wilmington, DE; Pacto Medical, Inc., Newark, DE; Shawmut LLC, West Bridgewater, MA; US Medical Glove, Harvard, IL; Univercells S.A., Charleroi, BELGIUM; and Vivaldi Biosciences Inc., Fort Collins, CO, have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and the BioMaPConsortium intends to file additional written notifications disclosing all changes in membership. On January 5, 2024, the BioMaPConsortium filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on April 16, 2024 (89 FR 26923). The last notification was filed with the Department on July 11, 2024. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on October 11, 2024 (89 FR 82628). Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. [FR Doc. 2024–30402 Filed 12–19–24; 8:45 am] BILLING CODE P E:\FR\FM\20DEN1.SGM 20DEN1

Agencies

[Federal Register Volume 89, Number 245 (Friday, December 20, 2024)]
[Notices]
[Page 104212]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30402]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Biopharmaceutical Manufacturing Preparedness 
Consortium

    Notice is hereby given that, on October 3, 2024, pursuant to 
section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Biopharmaceutical 
Manufacturing Preparedness Consortium (``BioMaP-Consortium'') has filed 
written notifications simultaneously with the Attorney General and the 
Federal Trade Commission disclosing changes in its membership. The 
notifications were filed for the purpose of extending the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances.
    Specifically, Asimov, Inc., Boston, MA; Bayer Healthcare LLC, 
Whippany, NJ; CHIMunomics, Ltd., Horsell, UNITED KINGDOM; Carnegie 
Mellon University, Pittsburgh, PA; Emergent Product Development 
Gaithersburg, Inc., Gaithersburg, MD; Enzene, Inc., Pennington, NJ; GE 
Medical Systems Information Technologies, Inc. d.b.a. GE HealthCare 
Technology & Innovation Center, Niskayuna, NY; Just-Evotec Biologics, 
Seattle, WA; Medbio LLC, Grand Rapids, MI; Molding Services of 
Illinois, Inc., Olney, IL; Novas Bio, Inc., Union City, CA; Qoolabs, 
Inc., Carlsbad, CA; SPOC Proteomics, Inc., Scottsdale, AZ; SaniSure, 
Inc., Camarillo, CA; AlphaGem Bio, Inc., Fremont, CA; Azure Medical, 
Inc., La Verne, CA; BioFactura, Inc., Frederick, MD; Brightstar 
Innovations Group LLC, Arlington, VA; Croda, Inc., Mill Hall, PA; 
Hamilton Company, Reno, NV; Komo Biosciences, Inc., Cambridge, MA; 
Mustard Seed PMO LLC, West Chester, PA; Nephron Nitrile LLC, West 
Columbia, SC; Rutgers University, Piscataway, NJ; The Tiny Cargo 
Company, Roanoke, VA; VGXI, Inc., Conroe, TX; Wild Microbes Company, 
Cambridge, MA; Arcology, Inc., Culver City, CA; Avery Digital Data, 
Inc., La Jolla, CA; Louis M Gerson Co, Inc., Middleboro, MA; Mark Cuban 
Cost Plus Drug Company, PBC, Dallas, TX; Vulcan Bioworks LLC, Dover, 
DE; Arcturus Therapeutics Holdings, Inc., San Diego, CA; Dentec Safety 
Specialists Corp., Lenexa, KS; Guide Biomedical Solutions LLC, Media, 
PA; Integral Molecular, Philadelphia, PA; Shreenika Pioneering, San 
Diego, CA; Applied Research Associates, Albuquerque, NM; DemeTech 
Corp., Miami, FL; Quantoom Biosciences SA, Nivelles, BELGIUM; Reusable 
Respirators LLC, Panama City, FL; SafeSource Direct, LLC, Broussard, 
LA; Vaxine Pty Ltd., Warradale, AUSTRALIA; 3M Company, St. Paul, MN; 
Amneal Pharmaceuticals of New York, LLC, Brookhaven, NY; CMMCM LLC, Las 
Vegas, NV; Foothill Scientific Associates, Lake Forest, CA; Innerspace 
GmbH, Insnbruck, AUSTRIA; Jurata Thin Film, Inc., Chapel Hill, NC; LTS 
Lohmann Therapie-Systeme AG, Andernach, GERMANY; O&M Halyard, Inc., 
Alpharetta, GA; PNUVAX, Inc., Wilmington, DE; Pacto Medical, Inc., 
Newark, DE; Shawmut LLC, West Bridgewater, MA; US Medical Glove, 
Harvard, IL; Univercells S.A., Charleroi, BELGIUM; and Vivaldi 
Biosciences Inc., Fort Collins, CO, have been added as parties to this 
venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and the BioMaP-Consortium intends to 
file additional written notifications disclosing all changes in 
membership.
    On January 5, 2024, the BioMaP- Consortium filed its original 
notification pursuant to section 6(a) of the Act. The Department of 
Justice published a notice in the Federal Register pursuant to section 
6(b) of the Act on April 16, 2024 (89 FR 26923).
    The last notification was filed with the Department on July 11, 
2024. The Department of Justice published a notice in the Federal 
Register pursuant to section 6(b) of the Act on October 11, 2024 (89 FR 
82628).

Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-30402 Filed 12-19-24; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.